BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium longum {B.Longum } - Shigella flexneri |
👶
Bifidobacterium longum Administration Diminishes Parasitemia and Inflammation During Plasmodium berghei Infection in Mice. Journal of inflammation research (J Inflamm Res ) Vol: 16 Issue Pages: 1393-1404 Pub: 2023 Epub: 2023 Mar 27 Authors Fitri LE , Sardjono TW , Winaris N , Pawestri AR , Endharti AT , Norahmawati E , Handayani D , Kurniawan SN , Azizah S , Alifia LI , Asiyah R , Ayuningtyas TR , Html Article Publication |
| bifidobacterium longum {B.Longum } - Shigella flexneri |
👶
Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. Nutrients (Nutrients ) Vol: 15 Issue 6 Pages: Pub: 2023 Mar 21 Epub: 2023 Mar 21 Authors De Oliveira FL , Salgaço MK , de Oliveira MT , Mesa V , Sartoratto A , Peregrino AM , Ramos WS , Sivieri K , Publication |
| bifidobacterium longum {B.Longum } - Shigella flexneri |
👶
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
